|Don Spence, President and CEO|
|Revenue||$1.05 billion USD|
Number of employees
|Slogan||Respond your skills|
In 1976, company founder Gerald McGinnis opened the company's first manufacturing facility for anesthesia masks near Pittsburgh, Pennsylvania. Previous product research and manufacturing had occurred in the founder's kitchen. Other early products included endotrachial and tracheostomy products.
The company introduced the first continuous positive airway pressure (CPAP) machine for the treatment of sleep apnea in 1985. Three years later, in 1988, the company went public under the stock ticker symbol RESP. In 1992, Respironics received a patent for bi-level technology. This technology was originally intended as an improvement on CPAP, however, its use has expanded into the treatment of other breathing disorders such as chronic obstructive pulmonary disease (COPD).
Other significant milestones were the acquisition of the ventilator company, LIFECARE International in 1996, sleep apnea competitor, Healthdyne Technologies in 1998 and medical monitor and sensor leader, Novametrix in 2002.
The firm's products includes devices for the diagnosis and treatment of sleep apnea including CPAP and bi-level (BiPAP) machines, oxygen concentrators for patients requiring supplemental oxygen, infant apnea monitors for infants at risk of SIDS, asthma treatment solutions and hospital ventilators.
On March 14, 2008, Philips announced completion of tender offer to acquire Respironics. 
- "Company Profile for Respironics, Inc (RESP)". Retrieved 2008-10-02.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
- Philips to Acquire Respironics for USD $66.00 Per Share